Oligometastatic Prostate Cancer: A Shrinking Subset or an Opportunity for Cure?
Author:
Affiliation:
1. Division of Hematology, Oncology, and Transplantation, University of Minnesota, Minneapolis, MN
2. Department of Radiation Oncology, University of Pennsylvania, Philadelphia, PA
3. Department of Urology, Northwestern University, Chicago, IL
Abstract
Publisher
American Society of Clinical Oncology (ASCO)
Subject
General Medicine
Link
https://ascopubs.org/doi/pdfdirect/10.1200/EDBK_239041
Reference71 articles.
1. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries
2. Oligometastases.
3. Stratification of patients with metastatic prostate cancer based on extent of disease on initial bone scan
4. Extent of Disease Based on Initial Bone Scan: Important Prognostic Predictor for Patients with Metastatic Prostatic Cancer
5. Is there a favorable subset of patients with prostate cancer who develop oligometastases?
Cited by 41 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Progress in Oligometastatic Prostate Cancer: Emerging Imaging Innovations and Therapeutic Approaches;Cancers;2024-01-24
2. Metastasis-directed therapy: new standard or too early to change paradigm?;memo - Magazine of European Medical Oncology;2023-12-29
3. Clinical Usefulness of Prostate-specific Membrane Antigen-ligand Positron Emission Tomography/Computed Tomography for the Detection of Prostate Cancer Biochemical Recurrence after Primary Radiation Therapy in Patients with Prostate-specific Antigen Below the Phoenix Threshold: Systematic Review and Meta-analysis;Clinical Oncology;2023-12
4. Predictors of Recurrence After Metastasis-directed Therapy in Oligorecurrent Prostate Cancer Following Radical Prostatectomy;European Urology Oncology;2023-12
5. Prostate-specific antigen doubling time predicts the efficacy of site-directed therapy for oligoprogressive castration-resistant prostate cancer;Prostate International;2023-12
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3